5,6-MDO-DiPT

5,6-MDO-DiPT
Clinical data
Other names	5,6-Methylenedioxy-N,N-diisopropyltryptamine
Identifiers
	IUPAC name N-[2-(5H-[1,3]dioxolo[4,5-f]indol-7-yl)ethyl]-N-propan-2-ylpropan-2-amine;
CAS Number	9P8WPL88C4 ;
PubChem CID	13141004;
ChemSpider	10524336;
UNII	9P8WPL88C4;
ChEMBL	ChEMBL368261;
Chemical and physical data
Formula	C17H24N2O2
Molar mass	288.391 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES CC(C)N(CCC1=CNC2=CC3=C(C=C21)OCO3)C(C)C;
	InChI InChI=1S/C17H24N2O2/c1-11(2)19(12(3)4)6-5-13-9-18-15-8-17-16(7-14(13)15)20-10-21-17/h7-9,11-12,18H,5-6,10H2,1-4H3; Key:MAICYUOZXYUWMJ-UHFFFAOYSA-N;

5,6-MDO-DiPT, or 5,6-methylenedioxy-N,N-diisopropyltryptamine, is a lesser-known psychedelic drug. It is the 5,6-methylenedioxy analog of DiPT. 5,6-MDO-DiPT was first synthesized by Alexander Shulgin. It is mentioned in his book TiHKAL (Tryptamines I Have Known and Loved), but 5,6-MDO-DiPT was never tested to determine what effects it produces, if any. Very little data exists about the pharmacological properties, metabolism, and toxicity of 5,6-MDO-DiPT.